JPWO2020172528A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020172528A5 JPWO2020172528A5 JP2021549227A JP2021549227A JPWO2020172528A5 JP WO2020172528 A5 JPWO2020172528 A5 JP WO2020172528A5 JP 2021549227 A JP2021549227 A JP 2021549227A JP 2021549227 A JP2021549227 A JP 2021549227A JP WO2020172528 A5 JPWO2020172528 A5 JP WO2020172528A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- seq
- acid sequence
- variants
- cdr2
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962809475P | 2019-02-22 | 2019-02-22 | |
| US62/809,475 | 2019-02-22 | ||
| PCT/US2020/019215 WO2020172528A1 (en) | 2019-02-22 | 2020-02-21 | Albumin binding antibodies and use thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022520998A JP2022520998A (ja) | 2022-04-04 |
| JP2022520998A5 JP2022520998A5 (https=) | 2023-02-28 |
| JPWO2020172528A5 true JPWO2020172528A5 (https=) | 2023-02-28 |
Family
ID=72144485
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021549227A Pending JP2022520998A (ja) | 2019-02-22 | 2020-02-21 | アルブミン結合抗体及びその使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US12479909B2 (https=) |
| EP (1) | EP3927740A4 (https=) |
| JP (1) | JP2022520998A (https=) |
| CN (1) | CN113508134B (https=) |
| TW (1) | TW202045545A (https=) |
| WO (1) | WO2020172528A1 (https=) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11629340B2 (en) | 2017-03-03 | 2023-04-18 | Obsidian Therapeutics, Inc. | DHFR tunable protein regulation |
| EP3806889A4 (en) * | 2018-06-18 | 2022-07-13 | Anwita Biosciences, Inc. | CYTOKI FUSION PROTEINS AND USES THEREOF |
| TW202128961A (zh) | 2019-11-20 | 2021-08-01 | 美商安維塔生物科學股份有限公司 | 細胞激素融合蛋白及其醫藥組合物及治療應用 |
| US11897930B2 (en) | 2020-04-28 | 2024-02-13 | Anwita Biosciences, Inc. | Interleukin-2 polypeptides and fusion proteins thereof, and their pharmaceutical compositions and therapeutic applications |
| EP4171611A4 (en) | 2020-07-30 | 2024-10-02 | Anwita Biosciences, Inc. | Interleukin-22 fusion proteins, and their pharmaceutical compositions and therapeutic applications |
| CN116419973A (zh) * | 2020-10-02 | 2023-07-11 | 新加坡科技研究局 | 用于蛋白质生产和筛选的表达系统 |
| JP2023549537A (ja) * | 2020-11-16 | 2023-11-27 | エイビー セラピューティクス インコーポレイテッド | 多重特異性抗体およびその使用方法 |
| CN117042788A (zh) * | 2020-12-08 | 2023-11-10 | 佳努克斯治疗公司 | 半衰期延长组合物和方法 |
| CN117545504A (zh) * | 2021-06-07 | 2024-02-09 | 上海济煜医药科技有限公司 | 抗人血清白蛋白的抗原结合蛋白 |
| JP2025517120A (ja) * | 2022-05-05 | 2025-06-03 | インヒブルクス バイオサイエンシズ インコーポレイテッド | アルブミン結合ポリペプチド及びその使用 |
| EP4573119A1 (en) * | 2022-08-17 | 2025-06-25 | Institut National de la Santé et de la Recherche Médicale | Improved anti-albumin nanobodies and their uses |
| WO2024051796A1 (en) * | 2022-09-09 | 2024-03-14 | Wuxi Biologics (Shanghai) Co., Ltd. | Albumin binding proteins, fusion proteins and uses thereof |
| WO2024097639A1 (en) * | 2022-10-31 | 2024-05-10 | Modernatx, Inc. | Hsa-binding antibodies and binding proteins and uses thereof |
| JP2026506075A (ja) | 2023-02-17 | 2026-02-20 | アブリンクス エン．ヴェー． | 新生児型ｆｃ受容体に結合するポリペプチド |
| WO2024236068A1 (en) * | 2023-05-17 | 2024-11-21 | Navigo Proteins | Affinity ligand for a single chain antibody fragment specific for serum albumin |
| NL2036011B1 (en) | 2023-10-12 | 2025-04-30 | Synapse Res Institute | Molecules for reversing anti-coagulant activity of direct oral anticoagulants |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004041867A2 (en) | 2002-11-08 | 2004-05-21 | Ablynx N.V. | Camelidae antibodies against imminoglobulin e and use thereof for the treatment of allergic disorders |
| EP2102244A2 (en) | 2006-12-19 | 2009-09-23 | Ablynx N.V. | Amino acid sequences directed against a metalloproteinase from the adam family and polypeptides comprising the same for the treatment of adam-related diseases and disorders |
| EP2692736B1 (en) | 2008-10-14 | 2018-04-18 | National Research Council Of Canada | Bsa-specific antibodies |
| JP2012532620A (ja) | 2009-07-16 | 2012-12-20 | グラクソ グループ リミテッド | 改良型抗血清アルブミン結合単一可変ドメイン |
| US9556273B2 (en) * | 2010-03-29 | 2017-01-31 | Vib Vzw | Anti-macrophage mannose receptor single variable domains for targeting and in vivo imaging of tumor-associated macrophages |
| JP2013537421A (ja) * | 2010-08-20 | 2013-10-03 | グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッド | 改良された抗血清アルブミン結合変異体 |
| AU2013201422B2 (en) * | 2012-01-23 | 2015-04-09 | Ablynx Nv | Sequences directed against hepatocyte growth factor (HFG) and polypeptides comprising the same for the treatment of cancers and/or tumors |
| BR112014020694A2 (pt) * | 2012-02-15 | 2018-05-08 | Amunix Operating Inc. | proteína de fusão do fator viii compreendendo polipeptídeo do fator viii fusionado a polipeptí-deo recombinante estendido (xten) e seu método de fabricação, ácido nucleico, vetores, célula hospedeira, bem como composição farmacêutica e seu uso no tratamento de coagulopatia, episódio de hemorragia e hemofilia a |
| WO2016034968A1 (en) | 2014-09-02 | 2016-03-10 | Pfizer Inc. | Therapeutic antibody |
| WO2016081639A1 (en) | 2014-11-19 | 2016-05-26 | Genentech, Inc. | Antibodies against bace1 and use thereof for neural disease immunotherapy |
| EA201792573A1 (ru) * | 2015-05-21 | 2018-04-30 | Харпун Терапьютикс, Инк. | Триспецифические связанные белки и способы их применения |
| CN115925919A (zh) * | 2015-11-13 | 2023-04-07 | 埃博灵克斯股份有限公司 | 改进的血清白蛋白结合免疫球蛋白可变结构域 |
| JP7101621B2 (ja) * | 2016-05-20 | 2022-07-15 | ハープーン セラピューティクス，インク． | 単一ドメイン血清アルブミン結合タンパク質 |
| RU2022101604A (ru) * | 2016-12-07 | 2022-03-29 | Аблинкс Нв | Улучшенные отдельные вариабельные домены иммуноглобулина, связывающиеся с сывороточным альбумином |
| AU2018265856B2 (en) | 2017-05-12 | 2023-04-27 | Harpoon Therapeutics, Inc. | Mesothelin binding proteins |
| DK3661954T3 (da) * | 2017-08-03 | 2022-04-19 | Amgen Inc | Interleukin-21-muteiner og fremgangsmåder til behandling |
| CA3076250A1 (en) * | 2017-10-02 | 2019-04-11 | Vib Vzw | Compounds to inhibit bacterial s-layer protein assembly |
| EP3806889A4 (en) | 2018-06-18 | 2022-07-13 | Anwita Biosciences, Inc. | CYTOKI FUSION PROTEINS AND USES THEREOF |
| TW202128961A (zh) * | 2019-11-20 | 2021-08-01 | 美商安維塔生物科學股份有限公司 | 細胞激素融合蛋白及其醫藥組合物及治療應用 |
| EP4171611A4 (en) * | 2020-07-30 | 2024-10-02 | Anwita Biosciences, Inc. | Interleukin-22 fusion proteins, and their pharmaceutical compositions and therapeutic applications |
-
2020
- 2020-02-21 CN CN202080015296.8A patent/CN113508134B/zh active Active
- 2020-02-21 JP JP2021549227A patent/JP2022520998A/ja active Pending
- 2020-02-21 WO PCT/US2020/019215 patent/WO2020172528A1/en not_active Ceased
- 2020-02-21 US US17/432,488 patent/US12479909B2/en active Active
- 2020-02-21 EP EP20759885.5A patent/EP3927740A4/en not_active Withdrawn
- 2020-02-21 TW TW109105677A patent/TW202045545A/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPWO2020172528A5 (https=) | ||
| US10047163B2 (en) | Multispecific constructs | |
| KR101782487B1 (ko) | 신규 항-메소텔린 항체 및 이를 포함하는 조성물 | |
| US20160009824A1 (en) | Tetravalent bispecific antibodies | |
| RU2015140917A (ru) | Биспецифические антигенсвязывающие молекулы, активирующие т-клетки | |
| JP2023540799A (ja) | 多重特異性免疫標的化分子及びその使用 | |
| RU2019123613A (ru) | Биспецифические антигенсвязывающие молекулы, содержащие антитело к4-1вв, клон 20н4.9 | |
| CN113480656A (zh) | 抗ror1抗体 | |
| RU2015140915A (ru) | Биспецифические антигенсвязывающие молекулы, активирующие т-клетки | |
| JP7356726B2 (ja) | タンパク性ヘテロ二量体及びその使用 | |
| CN115057936A (zh) | 异源二聚体多特异性抗体形式 | |
| CA2985700A1 (en) | T cell recruiting polypeptides based on cd3 reactivity | |
| CN114341186A (zh) | 双特异性抗LRRC15和CD3ε抗体 | |
| JP2023159379A (ja) | Ｐｄ－１とｖｅｇｆを標的とした四価二重特異性抗体、その製造方法および用途 | |
| CN115397852A (zh) | 工程化抗il-2抗体 | |
| CN118076387A (zh) | 靶向表达cdh17的肿瘤的多特异性抗体及其制备和使用方法 | |
| WO2022262678A1 (zh) | 一种多特异性抗原结合蛋白及其应用 | |
| TWI690539B (zh) | 一個需依賴標靶細胞使T細胞接合及活化之不對稱異二聚Fc-ScFv融合抗體形式及其在癌症治療上之應用 | |
| TW202317636A (zh) | 靶向egfr及her3的雙特異性四價抗體 | |
| CN114786720A (zh) | TriAx抗体的组合物及其制备和使用方法 | |
| CN117279951A (zh) | 抗5t4抗体及其用途 | |
| WO2020192648A1 (en) | Proteinaceous heterodimer and use thereof | |
| WO2024253595A1 (en) | MULTISPECIFIC ANTIGEN BINDING PROTEIN AGAINST EpCAM | |
| CN121263447A (zh) | Trop2抗体 | |
| CN120344558A (zh) | 双特异性/多特异性抗体及其用途 |